日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Role of Tumor Microenvironment in Triple-Negative Breast Cancer and Its Therapeutic Targeting

肿瘤微环境在三阴性乳腺癌中的作用及其治疗靶点

期刊:Cells
影响因子:5.2
doi:10.3390/cells14171353
Vuletic, Ana; Mirjacic Martinovic, Katarina; Jurisic, Vladimir
肿瘤
肿瘤免疫
乳腺癌
肿瘤微环境
发表日期：2025
文献求助 收藏

Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents.

开创性的首创 HDAC-ROCK 抑制剂作为潜在的多靶点抗癌药物

期刊:Future Medicinal Chemistry
影响因子:3.4
doi:10.1080/17568919.2025.2459589
Beljkas Milan, Ruzic Dusan, Djuric Ana, Vuletic Ana, Tchiehe Guilaine Nchugoua, Jallet Corinne, Cadet-Daniel Véronique, Arimondo Paola B, Santibanez Juan F, Srdic-Rajic Tatjana, Nikolic Katarina, Oljacic Slavica, Petkovic Milos
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

通过三维定量构效关系（3D-QSAR）和分子对接研究开发新型ROCK抑制剂：多靶点药物设计的框架

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics16101250
Beljkas, Milan; Petkovic, Milos; Vuletic, Ana; Djuric, Ana; Santibanez, Juan Francisco; Srdic-Rajic, Tatjana; Nikolic, Katarina; Oljacic, Slavica
3D/类器官
ROCK
发表日期：2024
文献求助 收藏

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals

检测哺乳期妇女、初次感染者和既往感染者对SARS-CoV-2 BNT162b2疫苗的体液和细胞免疫反应

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-33516-1
Cavic, Milena; Nesic, Andrijana; Mirjacic Martinovic, Katarina; Vuletic, Ana; Besu Zizak, Irina; Tisma Miletic, Nevena; Krivokuca, Ana; Jankovic, Radmila; Gavrovic-Jankulovic, Marija
炎症/感染
细胞生物学
SARS-CoV-2
免疫/内分泌
发表日期：2023
文献求助 收藏